Lista de obras - József Toldi - Dominio Público Uruguay

A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study

artículo científico publicado en 2009

Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach.

artículo científico publicado en 2011

Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain.

artículo científico publicado en 2016

Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism

artículo científico

Changing the face of kynurenines and neurotoxicity: therapeutic considerations

artículo científico publicado en 2015

Dementia, stroke and migraine--some common pathological mechanisms.

artículo científico publicado en 2010

Effects of blood glutamate scavenging on cortical evoked potentials

artículo científico publicado en 2010

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

artículo científico publicado en 2015

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

scientific article published on April 2011

Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo

artículo científico publicado en 2006

Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System

artículo científico publicado en 2016

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.

artículo científico publicado en 2014

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).

artículo científico publicado en 2016

Kynurenate derivative attenuates the nitroglycerin-induced CamKIIα and CGRP expression changes

artículo científico publicado en 2009

Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells

artículo científico publicado en 2018

Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus

artículo científico publicado en 2008

Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives

artículo científico publicado en 2011

Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects

artículo científico publicado en 2017

Kynurenines and headache.

artículo científico publicado en 2011

Kynurenines in Parkinson's disease: therapeutic perspectives.

artículo científico publicado en 2011

Kynurenines in neurodegenerative disorders: therapeutic consideration.

artículo científico publicado en 2004

Kynurenines in the CNS: recent advances and new questions.

artículo científico publicado en 2012

Kynurenines, neurodegeneration and Alzheimer's disease

artículo científico publicado en 2010

Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction.

artículo científico publicado en 2012

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

artículo científico publicado en 2015

Mental Disturbances in Parkinson's Disease and Related Disorders: The Role of Excitotoxins ⬇️

artículo científico publicado el 1 de enero de 2014

Migraine, neurogenic inflammation, drug development - pharmacochemical aspects

artículo científico publicado en 2017

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

artículo científico publicado en 2007

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

artículo científico publicado en 2012

Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus

artículo científico publicado en 2009

Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues

artículo científico publicado en 2016

Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design

artículo científico

Novel tracing paradigms--genetically engineered herpesviruses as tools for mapping functional circuits within the CNS: present status and future prospects.

artículo científico publicado en 2004

Oestrogen-dependent tracing in the rat CNS after pseudorabies virus infection.

artículo científico publicado en 2002

Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex

artículo científico publicado en 2014

Promising therapeutic agents for the treatment of Parkinson's disease

artículo científico publicado en 2016

Role of kynurenines in the central and peripheral nervous systems

artículo científico publicado en 2005

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.

artículo científico publicado en 2012

Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.

artículo científico publicado en 2015

Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice.

artículo científico publicado en 2017

Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy.

scientific article published on January 2011

The Role of Kynurenine Pathway in Pain and Migraine

scholarly article published 2015

The Role of the Kynurenine Pathway in Neurodegenerative Diseases

The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors ⬇️

artículo científico publicado el 18 de diciembre de 2013

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

artículo científico publicado en 2009

The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications

artículo científico publicado en 2012

Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.

artículo científico publicado en 2013

Use of a recombinant pseudorabies virus to analyze motor cortical reorganization after unilateral facial denervation.

artículo científico publicado en 2005

Lista de obras de József Toldi

A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study

Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach.

Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain.

Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism

Changing the face of kynurenines and neurotoxicity: therapeutic considerations

Dementia, stroke and migraine--some common pathological mechanisms.

Effects of blood glutamate scavenging on cortical evoked potentials

Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo

Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System

Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.

Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).

Kynurenate derivative attenuates the nitroglycerin-induced CamKIIα and CGRP expression changes

Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells

Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus

Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives

Kynurenines and PACAP in Migraine: Medicinal Chemistry and Pathogenetic Aspects

Kynurenines and headache.

Kynurenines in Parkinson's disease: therapeutic perspectives.

Kynurenines in neurodegenerative disorders: therapeutic consideration.

Kynurenines in the CNS: recent advances and new questions.

Kynurenines, neurodegeneration and Alzheimer's disease

Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction

Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction.

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

Mental Disturbances in Parkinson's Disease and Related Disorders: The Role of Excitotoxins ⬇️

Migraine, neurogenic inflammation, drug development - pharmacochemical aspects

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus

Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues

Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design

Novel tracing paradigms--genetically engineered herpesviruses as tools for mapping functional circuits within the CNS: present status and future prospects.

Oestrogen-dependent tracing in the rat CNS after pseudorabies virus infection.

Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex

Promising therapeutic agents for the treatment of Parkinson's disease

Role of kynurenines in the central and peripheral nervous systems

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.

Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.

Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice.

Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy.

The Role of Kynurenine Pathway in Pain and Migraine

The Role of the Kynurenine Pathway in Neurodegenerative Diseases

The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors ⬇️

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications

Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.

Use of a recombinant pseudorabies virus to analyze motor cortical reorganization after unilateral facial denervation.